Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

Xenobiotica; the Fate of Foreign Compounds in Biological Systems
Shigeru FurutaH Sano

Abstract

1. The inhibitory effects of cimetidine, nizatidine and omeprazole on the metabolic activity of CYP2C9, 2C19, 2D6 and 3A were investigated in human liver microsomes. Both cimetidine and omeprazole inhibited each of the CYP subfamily enzymes; in particular, omeprazole extensively inhibited the hydroxylation of S-mephenytoin (CYP2C19, Ki = 7.1 microM). Nizatidine exhibited no inhibition of any of the CYP isoforms examined. 2. Cimetidine inhibited the hydroxylation of tolbutamide but not of diclofenac, whereas omeprazole inhibited the hydroxylation of diclofenac but not that of tolbutamide. The ability to inhibit CYP2C9 varied with incubation time, as measured by the metabolic rate constant for the substrates. Therefore, suitable substrates and incubation times must be selected in inhibition studies examining metabolic clearance and the mechanism of inhibition of these drugs. 3. Nizatidine did not inhibit the metabolism of cisapride, glibenclamide, benidipine and simvastatin. Omeprazole inhibited the metabolism of cisapride (Ki = 0.4 microM), glibenclamide (11.7 microM) and benidipine (6.5 microM), whereas cimetidine inhibited the metabolism of glibenclamide (11.6 microM). To avoid drug-drug interactions, care needs to be taken to...Continue Reading

References

Dec 1, 1991·Gastroenterology·R G KnodellF P Guengerich
Jan 1, 1987·Scandinavian Journal of Gastroenterology. Supplement·U Klotz
Jun 1, 1988·Clinical Pharmacology and Therapeutics·G R AronoffJ T Callaghan
Dec 1, 1995·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A RieutordA S Gross
Sep 1, 1996·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T A Bedford, D J Rowbotham
May 1, 1997·British Journal of Clinical Pharmacology·A C ParkerI Choonara
Jun 13, 1998·European Journal of Drug Metabolism and Pharmacokinetics·M KatashimaT Iga
Aug 1, 1953·The Biochemical Journal·M DIXON

❮ Previous
Next ❯

Citations

Jul 20, 2002·International Clinical Psychopharmacology·U WernekeT A B Sanders
Apr 16, 2004·Journal of Pediatric Gastroenterology and Nutrition·Susan M Abdel-RahmanGregory L Kearns
May 6, 2005·Clinical Pharmacokinetics·Catherine LitalienChristophe Faure
Jan 22, 2004·Proceedings of the National Academy of Sciences of the United States of America·David J GranvilleRoberta A Gottlieb
Mar 6, 2012·Expert Opinion on Drug Metabolism & Toxicology·Justin D Lutz, Nina Isoherranen
Jul 31, 2009·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Tracey D Bradshaw, David R Bell
Mar 25, 2005·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·K H LiuJ G Shin
Jan 23, 2016·The Journal of Emergency Medicine·Daniel R Lasoff, Aaron Schneir
Dec 15, 2010·Thérapie·Leila ChebaneUNKNOWN Centres Régionaux de Pharmacovigilance Français
May 16, 2009·Drug Discovery Today·James M MullinJames J Thornton
Jan 9, 2007·Psychosomatics·Gary H WynnKelly L Cozza
Sep 21, 2006·The Veterinary Clinics of North America. Small Animal Practice·Lauren A Trepanier
Jan 8, 2008·Alimentary Pharmacology & Therapeutics·P A H M WijnenG H Koek
Dec 9, 2010·Journal of Thrombosis and Haemostasis : JTH·G P Miller
Dec 20, 2013·Chemical Biology & Drug Design·Chuan TianRuixin Zhu
Mar 11, 2015·British Journal of Clinical Pharmacology·Shlomi CohenFrancis B Mimouni
Jun 28, 2015·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tao Zhang
Mar 28, 2006·International Journal of Antimicrobial Agents·Dominique LevêqueRaoul Herbrecht
Sep 28, 2007·Clinical Pharmacology and Therapeutics·K SinghM Boffito
Nov 1, 2018·Journal of Veterinary Internal Medicine·Stanley L MarksMichael D Willard
May 20, 2008·CNS Drugs·Trino BaptistaSerge Beaulieu
Mar 1, 2002·British Journal of Cancer·F CaballeroE Vazquez
May 10, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Maria MadeiraGail D Bellward
Dec 29, 2016·Molecular Diversity·Nicole RügerAndreas Link

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.